Prolyl hydroxylase inhibitors
US8324208B2 · kind B2 · utility
10Cited by
2References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 22, 2007 |
| Grant date | Dec 4, 2012 |
| Priority date | — |
| Expiry date | Oct 17, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention described herein relates to certain pyrimidinetrione N-substituted glycine derivatives of formula (I)which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.